SUPPORT FOR P63 AS AN ADVERSE PROGNOSTIC MARKER IN MERKEL CELL CARCINOMA: REPORT ON A CANADIAN COHORT

Poster 233 RESIDENT

  • Fleming, Kirsten MD
  • Yen Ly, Thai MD FRCPC
  • Pasternak, Sylvia MD FRCPC
  • Godlewski, Marek MD MSc FRCPC
  • Doucette, Steve MSc
  • Walsh, Noreen MD FRCPC FRCPath (UK)

  • 1Dalhousie University and Capital District Health Authority, Halifax, Canada

    2Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY, USA

    3Saint John Regional Hospital, Horizon Health Network, Saint John, Canada

    4Research Methods Unit, Capital District Health Authority and Dalhousie, Halifax, Canada

Journal of Cutaneous Pathology 41(2):p 221, February 2014.
Copyright © 2014 John Wiley & Sons, Ltd